The role of distinct CD4 
Introduction
The continual exposure to a large number of air-borne pathogens within the respiratory tract, presents the immune system with a relentless challenge. An appropriate immune response encompasses the ability to discriminate between self and non-self, and importantly to differentiate between harmful and innocuous antigens. In order to protect the host, mechanisms must be in place to prevent deleterious reactions, such as immune responses to self-antigens, leading to autoimmune diseases, immune response to food antigens in the intestine or exaggerated immune responses to benign environmental antigens. The existence of suppressor T cells and their role in the maintenance of immune homeostasis was first proposed in the early 1970s [1] . However, the field eventually floundered because these T cells could not be phenotyped and attempts to clone the putative suppressor T cells failed. [2] [3] [4] . Since CD25 is expressed on all activated T cells, it is not an ideal marker for nTreg cells. Attempts to find alternative phenotypic markers lead to the discovery that these nTreg cells express the forkhead-winged helix transcription factor Foxp3. This transcription factor has been shown to be critical in the development and function of nTreg cells, as both mice and humans deficient in a functional Foxp3 protein develop autoimmune diseases [5, 6] . It has also been demonstrated that CD4 T cells in the periphery under the influence of TGF-β and retinoic acid [7, 8] . These peripherally converted Treg cells are induced during infection and cancer and also function to suppress effector T cells.
Recent studies have shown that subsets of Foxp3 + T cells can be distinguished based on differential expression of certain cell surface markers. For example, CD103 (α E β 7 integrin) is expressed at high levels on Foxp3 + T cells found in secondary lymphoid organs, whereas, the chemokine receptor CCR4, which is also present on Th1 cells, is expressed at high levels on Foxp3 + T cells found in the skin but not in the thymus [9, 10] . In addition, it is now apparent that Treg cells also express transcription factors previously associated with particular   effectors T cells, inducing the Th1 transcription factor, T-bet and the Th2 and Th17 related transcription factor, IRF4 [11, 12] . It is possible that common transcription factors facilitates shared homing receptors, allowing the Foxp3 [14, 15] . However, it is now apparent that the mechanism of immune suppression by Foxp3 + Treg cells is more complex than simply inhibiting IL-2 production and is mediated through a combination of both cellcontact dependent and independent mechanisms. It has been suggested that secretion of molecules, such as galectin-1 and fibrinogen-like protein 2 (FGLP2) play a role in suppression mediated by Foxp3 + nTreg cells. Galectin-1 is preferentially expressed in Treg cells and is upregulated upon TCR activation. Blocking of galectin -1 has been shown to significantly reduce the inhibitory properties of both mouse and human Treg cells [16] . FGLP2, a member of the fibrinogen superfamily, has been shown to be expressed in significantly higher levels in [21] . Similarly, Tr1 clones specific for filamentous haemaggultinin (FHA) from Bordetella pertussis were shown to be capable of suppressing proliferation and cytokine production by a Th1 clone against an unrelated antigen, influenza virus haemagglution [23] .
TGF-β has been shown to play a critical role in the induction of Treg cells both in vitro and in vivo [24, 25] . Interestingly, TGF-β also play an important role in the induction of proinflammatory Th17 cells [26] , although recent studies have suggested that TGF-β does not directly promote Th17 cell differentiation, but acts indirectly by inhibiting activating of Th1 and Th2 cell, the products of which can suppress development of Th17 cells [27] . It has been shown that nTreg cells can be converted to Th17 cells in response to IL-6 in conditions were TGF-β levels are limiting [28, 29] . In contrast, T cells that have been induced to become Treg cells under the influence of TGF-β are resistant to IL-6-induced conversion to Th17 [30] . TGF- has also been shown, in the presence of IL-4, to reprogramme established Th2 cells to lose their ability to produce Th2 cytokines and switch to IL-9 production; these cells have been called Th9 cells [31] . Treg cells that exclusively secrete TGF-β, known as Th3 cells, have also been described. These Th3 cells were originally identified in mice after oral tolerance induction to myelin basic protein (MBP) for their ability to suppress MBP-specific encephalomyelitis (EAE) in vivo in a TGF--dependent manner, as suppression was abrogated by injection of anti-TGF- antibody [33, 34] . Th3 cells provide help for IgA production and suppress both Th1 and Th2 cells [35] .
Furthermore, as TGF- is broadly expressed and acts on multiple cell types, TGF--secreting Th3 cells probably have a major role in many aspects of immune regulation and homeostasis [36] .
DC play a key role in the initiation and regulation of T cell responses and help to link the innate and adaptive immune systems. It has been suggested that plasmacytoid DC selectively promote the induction of Th1 cells, while myeloid DC favour the induction of Th2 cells.
However, it is more likely that the activation status of the DC, rather than the lineage, determines its ability to selectively promote T cell subtypes [22, 37] . Ligation of LAG-3 and CTLA-4 on 
Induction of Treg cells by respiratory pathogens

Mycobacterium tuberculosis
It is estimated that one third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis, a disease responsible for significant morbidity and mortality worldwide. 
B. pertussis
Infection with a number of pathogens is associated with the production of high levels of 
Implications for allergy and asthma
In atopic individuals, presentation of allergens to naïve T cells leads to the development of [70] . IL-10 promotes IgG4 production, an antibody isotype generally considered to be protective in the context of allergic responses; IgG4 has been shown to inhibit IgE [71] . Furthermore, it has been demonstrated that treatment with dexamethasone and vitamin D3 enhances IL-10-secreting Treg cells, which inhibit allergen-specific Th2 cells [72] . It has recently been reported that IL-23 and Th17 enhance airway inflammation by promoting neutrophil recruitment but also by enhancing Th2 cell-mediated eosinophilic inflammation in a murine asthma model [73] . Therefore, effective immunomodulatory therapies against asthma may need to suppress Th17 as well as Th2 responses.
Studies examining the relationship between allergies and parasitic infections have demonstrated that children with chronic helminth infection have reduced allergic responses to the house dust mite [74] . Infection of mice with the gastrointestinal nematode Heligmosomoides polygyrus was found to indiuced Treg cells that suppress experimentally induced airway allergy to the house dust mite allergen Der p1 [75] . These studies support the hypothesis that the induction of Treg cells by respiratory or enteric pathogens may play an important role in the protective effect of infections against the development of allergic disorders [76] . Furthermore, identification of immunomodulatory molecules, such as FHA from B. pertussis or products of helminth parasites [77] [78] that promote the development of Treg cells in vivo, may provide us with novel immunotherapeutic drugs for the prevention and treatment of autoimmune diseases and allergy (Fig 1) . Support for this possibility stems from the demonstration that parenteral administration of FHA to mice significantly ameliorated disease in a T-cell mediated model of In contrast to PBS-treated mice, FHA-treated mice had significantly reduced weight loss, reduced colon shrinkage and lower levels of inflammatory cytokines [79] .
Conclusions
Asthma, allergy and autoimmune diseases are still a major cause of morbidity and mortality in humans worldwide. For the most part, treatment of many of these disorders is heavily reliant on immunosuppressive drugs, which can lack specificity or have serious side effects. Approaches 
